Teradyne Is A Solid Buy
Its bread and butter testing business is a secular growth story and should recover in H2 and beyond from weakness in the mobile sector. But this sector generates lots of […]
Its bread and butter testing business is a secular growth story and should recover in H2 and beyond from weakness in the mobile sector. But this sector generates lots of […]
Revenue and margins are turning in the plagued Mobile/IoT division. The company got rid of a substantial liability and achieved a big cash injection. It is well placed to take […]
Boingo acquired Elauwit to shoot it into additional verticals beyond the military – a sensible move. Carrier offloading is the main driver of company results, and the importance of this […]
The shares of IntriCon have gone parabolic, and it’s not hard to see why. The main driver is the rapid increase in sales to Medtronic’s continuing glucose monitoring systems, and […]
The company was plagued by what management described as execution problems and the shares sold off big time. While the direct financial impact doesn’t seem to warrant the extent of […]
Finally SunPower is actually choosing its markets according to its core competencies, those in efficient panels. As a result, the company is exiting a number of markets and selling three […]
Better times are ahead for Acacia, once the highflyer in the optical network sector. The company had been plagued by a slowdown of Chinese demand and lately also by the […]
Revenue decline is pretty ugly due to saturation in the smartphone market, but management promises growth returns in 2020. The company has to make increased inroads in the Android space […]
We have been amazed with the price decline in Electro Scientific for some time, as we didn’t see the severe downturn that was being priced in. And as it turns […]
The Cypress 3.0 strategy gives the company a sensible direction and management’s execution so far impresses once again. Some of the company’s products are slowly getting a more ingrained position […]